Proquazone (Sandoz 43-715), An Unusually Potent Inhibitor of the Platelet Release Reaction and Malondialdehyde Formation
- 1 November 1977
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 156 (2) , 209-212
- https://doi.org/10.3181/00379727-156-39908
Abstract
Although proquazone is not an acid, its action on platelets is similar to that of a typical acidic non steroidal antiinflammatory drug: it inhibits the release reaction and associated production of malonidaldehyde without affecting primary aggregation caused by ADP or epinephrine, and it fails to inhibit the collagen-induced release which remains after maximal inhibition by aspirin. It is unusually active; it may have an effect in vitro at 11 nM, and is at least 50 times more active than indomethacin in preventing collagen-induced release from human platelets.This publication has 4 references indexed in Scilit:
- Sodium Arachidonate Can Induce Platelet Shape Change and Aggregation Which Are Independent of the Release ReactionScience, 1976
- MALONDIALDEHYDE FORMATION AS AN INDICATOR OF PROSTAGLANDIN PRODUCTION BY HUMAN PLATELETS1976
- Inhibition of Adenosine Diphosphate-Induced Secondary Aggregation and Other Platelet Functions by Acetylsalicylic Acid IngestionExperimental Biology and Medicine, 1968
- ALTERATION OF THE RESPONSE OF PLATELETS TO SURFACE STIMULI BY PYRAZOLE COMPOUNDSThe Journal of Experimental Medicine, 1967